Virotox
- Product NDC
- 43857-0411
- 11-digit product format
- 438570411
- Labeler code
- 43857
- Product ID
- 43857-0411_85f721d6-aee5-47e1-8232-1da1e15bca7e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Bovine, Thymus (Bovine), Belladonna, Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Pyrogenium
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2016-08-18
- Marketing end
- 2025-05-18
- Substance
- ECHINACEA ANGUSTIFOLIA; LOMATIUM DISSECTUM ROOT; MYRRH; NASTURTIUM OFFICINALE; TABEBUIA IMPETIGINOSA BARK; GOLDENSEAL; BOS TAURUS ADRENAL GLAND; BOS TAURUS THYMUS; ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; STRYCHNOS NUX-VOMICA SEED; RANCID BEEF
- Active strength
- 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 43857-0411 | D | Discontinued by firm | 2026-10-12 | ||
| excluded package | package | 43857-0411 | 43857-0411-1 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 43857-0411-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 43857-0411-1 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43857-0411-1 | 43857041101 | 30 mL in 1 BOTTLE, DROPPER (43857-0411-1) | 30 ml | 2016-08-18 | 2025-05-18 | No | No | Current |